Publikationen

2012

11 Chen Z, Gerhold-Ay A, Gebhard S, Boehm D, Solbach C, Lebrecht A, Battista M,Sicking I, Cotarelo 1C, Cadenas C, Marchan R, Stewart JD, Gehrmann M, Koelbl H,Hengstler JG, Schmidt M.  Immunoglobulin kappa C predicts overall survival innode-negative breast cancer.   PLoS One. 2012;7(9):e44741. doi:10.1371/journal.pone.0044741. Epub 2012 Sep 28.

10 Godoy P, Cadenas C, Hellwig B, Marchan R, Stewart J, Reif R, Lohr M, Gehrmann M, Rahnenführer J, Schmidt M, Hengstler JG.  Interferon-inducible guanylatebinding protein (GBP2) is associated with better prognosis in breast cancer andindicates an efficient T cell response.  Breast Cancer. 2012 Sep 22. [Epub ahead of print] 

9 Martin M, Müller K, Cadenas C, Hermes M, Zink M, Hengstler JG, Käs JA.  ERBB2overexpression triggers transient high mechanoactivity of breast tumor cells. Cytoskeleton (Hoboken). 2012 May;69(5):267-77. doi: 10.1002/cm.21023.   

8 Schmidt M, Hellwig B, Hammad S, Othman A, Lohr M, Chen Z, Boehm D, Gebhard S, Petry I, Lebrecht A, Cadenas C, Marchan R, Stewart JD, Solbach C, Holmberg L,Edlund K, Kultima HG, Rody A, Berglund A, Lambe M, Isaksson A, Botling J, Karn T,Müller V, Gerhold-Ay A, Cotarelo C, Sebastian M, Kronenwett R, Bojar H, Lehr HA, Sahin U, Koelbl H, Gehrmann M, Micke P, Rahnenführer J, Hengstler JG.  A Comprehensive Analysis of Human Gene Expression Profiles Identifies StromalImmunoglobulin ? C as a Compatible Prognostic Marker in Human Solid Tumors.  Clin Cancer Res. 2012 May;18(9):2695-2703.

7 Siggelkow W, Boehm D, Gebhard S, Battista M, Sicking I, Lebrecht A, Solbach C,Hellwig B, Rahnenführer J, Koelbl H, Gehrmann M, Marchan R, Cadenas C, Hengstler JG, Schmidt M.  Expression of aurora kinase A is associated with metastasis-freesurvival in node-negative breast cancer patients.  BMC Cancer. 2012 Nov 27;12:562.doi: 10.1186/1471-2407-12-562.

2011

6 Schmidt M, Petry IB, Böhm D, Lebrecht A, von Törne C, Gebhard S, Gerhold-Ay A, Cotarelo C, Battista M, Schormann W, Freis E, Selinski S, Ickstadt K, Rahnenführer J, Sebastian M, Schuler M, Koelbl H, Gehrmann M, Hengstler JG. Ep-CAM RNA expression predicts metastasis free survival in three cohorts of untreated node negative breast cancer. Breast Cancer Res Trea. 2011 Feb; 125(3):637-46

2010

5 Brase JC, Schmidt M, Fischbach T, Sültmann H, Bojar H, Koelbl H, Hellwig B, Rahnenführer J, Hengstler JG, Gehrmann MC. ERBB2 and TOP2A in breast cancer: a comprehensive analysis of gene amplification, RNA levels, and protein expression and their influence on prognosis and prediction. Clin Cancer Res. 2010 Apr 15;16(8):2391-401. doi: 10.1158/1078-0432.CCR-09-2471

4 Cadenas C, Franckenstein D, Schmidt M, Gehrmann M, Hermes M, Geppert B, Schormann W, Maccoux LJ, Schug M, Schumann A, Wilhelm C, Freis E, Ickstadt K, Rahenenfuehrer J, Baumbach JI, Sickmann A, Hengstler JG. Role of thioredoxin reductase 1 and thioredoxin interacting protein in prognosis of breast cancer.  Breast Cancer Res. 2010 Jun 28;12(3):R44. [Epub ahead of print]. doi:10.1186/bcr2599

3 Hellwig B, Hengstler JG, Schmidt M, Gehrmann MC, Schormann W, Rahnenführer J. Comparison of scores for bimodality of gene expression distributions and genome-wide evaluation of the prognostic relevance of high-scoring genes. BMC Bioinformatics. 2010 May 25;11:276.doi: 10.1186/1471-2105-11-276

2 Petry IB, Fieber E, Schmidt M, Gehrmann M, Gebhard S, Hermes H, Schormann W, Selinski S, Freis E, Schwender H, Brulport M, Ickstadt K, Rahnenführer J, Maccoux L, West J, Kölbl H, Schuler M, Hengstler JG. ERBB2 induces an antiapoptotic expression pattern of Bcl-2 family members in node-negative breast cancer. Clin Cancer Res. 2010 Jan 15;16(2):451-60.doi: 10.1158/1078-0432.CCR-09-1617

1 Schmidt M, Petry IB, Böhm D, Lebrecht A, von Törne C, Gebhard S, Gerhold-Ay a, Cotarelo C, Battista M, Schormann W, Freis E, Selinski S, Ickstadt K, Rahnenführer J, Sebastian M, Schuler M, Koelbl H, Gehrmann M, Hengstler JG. Ep-Cam RNA expression predicts metastasis-free survival in three cohorts of untreated node-negative breast cancer. Breast Cancer Res Treat. 2010 Mar 30. [Epub ahead of print]. doi:10.1007/s10549-010-0856-5